Trial intelligence / Profile preview

Role of Droperidol in Postoperative Vomiting

NCT00702442Phase 4Completed

Sponsor
Aristotle University of Thessaloniki
Start
Jun 2008
Primary completion
Jul 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in postoperative nausea and vomiting (PONV) comparing Placebo with Droperidol (2 arms). Primary endpoint: Vomiting episodes at 24 hours. Started Jun 2008; status: completed.

02

Drugs

droperidol
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on NCT00702442.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00702442.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call